Stem cell therapy in autism: Recent insights

Dario Siniscalco; Suresh Kannan; Neomar Semprún-Hernández; Adrien A. Eshraghi; Anna Lisa Brigida; Nicola Antonucci

doi:10.2147/SCCAA.S155410

Stem cell therapy in autism: Recent insights

Dario Siniscalco, Suresh Kannan, Neomar Semprún-Hernández, Adrien A. Eshraghi, Anna Lisa Brigida, Nicola Antonucci

Otolaryngology

Research output: Contribution to journal › Review article

6 Scopus citations

Abstract

Autism spectrum disorders (ASDs) are characterized by core domains: persistent deficits in social communication and interaction; restricted, repetitive patterns of behavior, interests, or activities. ASDs comprise heterogeneous and complex neurodevelopmental pathologies with well-defined inflammatory conditions and immune system dysfunction. Due to neurobiologic changes underlying ASD development, cell-based therapies have been proposed and applied to ASDs. Indeed, stem cells show specific immunologic properties, which make them promising candidates in ASD treatment. This comprehensive up-to-date review focuses on ASD cellular/ molecular abnormalities, potentially useful stem cell types, animal models, and current clinical trials on the use of stem cells in treating autism. Limitations are also discussed.

Original language	English (US)
Pages (from-to)	55-67
Number of pages	13
Journal	Stem Cells and Cloning: Advances and Applications
Volume	11
DOIs	https://doi.org/10.2147/SCCAA.S155410
State	Published - Jan 1 2018

Keywords

Autism spectrum disorder
Cell therapy
Immune dysfunction
Stem cell

ASJC Scopus subject areas

Medicine (miscellaneous)
Cell Biology

Access to Document

10.2147/SCCAA.S155410

Fingerprint Dive into the research topics of 'Stem cell therapy in autism: Recent insights'. Together they form a unique fingerprint.

Cite this

Siniscalco, D., Kannan, S., Semprún-Hernández, N., Eshraghi, A. A., Brigida, A. L., & Antonucci, N. (2018). Stem cell therapy in autism: Recent insights. Stem Cells and Cloning: Advances and Applications, 11, 55-67. https://doi.org/10.2147/SCCAA.S155410

@article{49ad72c7163c4758a3d7f7d81ec80756,

title = "Stem cell therapy in autism: Recent insights",

abstract = "Autism spectrum disorders (ASDs) are characterized by core domains: persistent deficits in social communication and interaction; restricted, repetitive patterns of behavior, interests, or activities. ASDs comprise heterogeneous and complex neurodevelopmental pathologies with well-defined inflammatory conditions and immune system dysfunction. Due to neurobiologic changes underlying ASD development, cell-based therapies have been proposed and applied to ASDs. Indeed, stem cells show specific immunologic properties, which make them promising candidates in ASD treatment. This comprehensive up-to-date review focuses on ASD cellular/ molecular abnormalities, potentially useful stem cell types, animal models, and current clinical trials on the use of stem cells in treating autism. Limitations are also discussed.",

keywords = "Autism spectrum disorder, Cell therapy, Immune dysfunction, Stem cell",

author = "Dario Siniscalco and Suresh Kannan and Neomar Sempr{\'u}n-Hern{\'a}ndez and Eshraghi, {Adrien A.} and Brigida, {Anna Lisa} and Nicola Antonucci",

year = "2018",

month = jan,

day = "1",

doi = "10.2147/SCCAA.S155410",

language = "English (US)",

volume = "11",

pages = "55--67",

journal = "Stem Cells and Cloning: Advances and Applications",

issn = "1178-6957",

publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Stem cell therapy in autism

T2 - Recent insights

AU - Siniscalco, Dario

AU - Kannan, Suresh

AU - Semprún-Hernández, Neomar

AU - Eshraghi, Adrien A.

AU - Brigida, Anna Lisa

AU - Antonucci, Nicola

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Autism spectrum disorders (ASDs) are characterized by core domains: persistent deficits in social communication and interaction; restricted, repetitive patterns of behavior, interests, or activities. ASDs comprise heterogeneous and complex neurodevelopmental pathologies with well-defined inflammatory conditions and immune system dysfunction. Due to neurobiologic changes underlying ASD development, cell-based therapies have been proposed and applied to ASDs. Indeed, stem cells show specific immunologic properties, which make them promising candidates in ASD treatment. This comprehensive up-to-date review focuses on ASD cellular/ molecular abnormalities, potentially useful stem cell types, animal models, and current clinical trials on the use of stem cells in treating autism. Limitations are also discussed.

AB - Autism spectrum disorders (ASDs) are characterized by core domains: persistent deficits in social communication and interaction; restricted, repetitive patterns of behavior, interests, or activities. ASDs comprise heterogeneous and complex neurodevelopmental pathologies with well-defined inflammatory conditions and immune system dysfunction. Due to neurobiologic changes underlying ASD development, cell-based therapies have been proposed and applied to ASDs. Indeed, stem cells show specific immunologic properties, which make them promising candidates in ASD treatment. This comprehensive up-to-date review focuses on ASD cellular/ molecular abnormalities, potentially useful stem cell types, animal models, and current clinical trials on the use of stem cells in treating autism. Limitations are also discussed.

KW - Autism spectrum disorder

KW - Cell therapy

KW - Immune dysfunction

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=85064884213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064884213&partnerID=8YFLogxK

U2 - 10.2147/SCCAA.S155410

DO - 10.2147/SCCAA.S155410

M3 - Review article

AN - SCOPUS:85064884213

VL - 11

SP - 55

EP - 67

JO - Stem Cells and Cloning: Advances and Applications

JF - Stem Cells and Cloning: Advances and Applications

SN - 1178-6957

ER -